Syndax Pharmaceuticals Inc. (SNDX) is predicted to post EPS of -0.49 in the upcoming quarter : This Stock is Ticking Every Box for Top Investors

Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) established initial surge of 4.43% at $23.58, as the Stock market unbolted on March 05, 2021. During the day, the stock rose to $24.23 and sunk to $21.71 before settling in for the price of $22.58 at the close. Taking a more long-term approach, SNDX posted a 52-week range of $6.88-$27.85.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Meanwhile, its Annual Earning per share during the time was -3.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 36.90%. This publicly-traded company’s shares outstanding now amounts to $44.16 million, simultaneously with a float of $44.09 million. The organization now has a market capitalization sitting at $1.05 billion. At the time of writing, stock’s 50-day Moving Average stood at $22.47, while the 200-day Moving Average is $18.66.

Let’s gauge the efficiency of the firm, which has a total of 35 employees. It has generated 43,343 per worker during the last fiscal year. Meanwhile, its income per employee was -1,601,343. The stock had 8.22 Receivables turnover and 0.02 Total Asset turnover. For the Profitability, stocks operating margin was -3792.95 and Pretax Margin of -3694.59.

Syndax Pharmaceuticals Inc. (SNDX) Ownership Facts and Figures

Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Syndax Pharmaceuticals Inc. industry. Syndax Pharmaceuticals Inc.’s current insider ownership accounts for 0.40%, in contrast to 78.88% institutional ownership. According to the most recent insider trade that took place on Mar 01, this organization’s Director sold 10,241 shares at the rate of 24.31, making the entire transaction reach 248,981 in total value, affecting insider ownership by 16,000. Preceding that transaction, on Feb 08, Company’s Chief Executive Officer sold 35,156 for 20.55, making the whole transaction’s value amount to 722,403. This particular insider is now the holder of 48,336 in total.

Syndax Pharmaceuticals Inc. (SNDX) Earnings and Revenue Records

Going through the last 3-months fiscal report unveiled on the 9/29/2020, it has been observed that the corporation posted -$0.46 earnings per share (EPS) during the time that was less the consensus figure (set at -$0.44) by -$0.02. This company achieved a net margin of -3694.59 while generating a return on equity of -132.43. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.

Syndax Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 36.90% and is forecasted to reach -1.80 in the upcoming year.

Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) Trading Performance Indicators

Let’s observe the current performance indicators for Syndax Pharmaceuticals Inc. (SNDX). It’s Quick Ratio in the last reported quarter now stands at 11.70. The Stock has managed to achieve an average true range (ATR) of 1.76. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 697.97.

In the same vein, SNDX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.88, a figure that is expected to reach -0.49 in the next quarter, and analysts are predicting that it will be -1.80 at the market close of one year from today.

Technical Analysis of Syndax Pharmaceuticals Inc. (SNDX)

Now, what If we examine the latest scores posted by [Syndax Pharmaceuticals Inc., SNDX]. During the last 5-days, its volume was better the volume of 0.61 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 31.14% While, its Average True Range was 1.86.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Raw Stochastic average of Syndax Pharmaceuticals Inc. (SNDX) in the period of the previous 100 days is set at 67.58%, which indicates a major rise in contrast to 67.01% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 73.44% that was higher than 68.40% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Recent Articles

COVID-19 Testing Frequency Is Unlikely To Decline And Abbott Labs (ABT) Is Main Beneficiary

The stock of Abbott Labs (ABT) has gained almost 40% over the past year. Sales of COVID-19 tests for the ABT stock were strong,...

What is behind this recent momentum of Ebix Inc. (NASDAQ: EBIX)

Despite the decline in February, Ebix Inc. (EBIX) gained double-digits in March, partially recovering from the drop. EBIX was trading at $ 31.06 on...

General Motors (GM) To Invest Almost $30 Billion in EV’s

For the first time in its history, General Motors (GM) plans on investing around $30 billion into electric vehicle development and production. Many investors...

The Fundamentals Of Designer Brands Inc. (DBI) Are A Compelling Reason To Be Bullish On The Stock

Some investors were pleased to see that the DBI stock's executives that sells high-end footwear, Designer Brands Inc(DBI), acquired new shares of their company...

The Fundamental Case for and Against Sage Therapeutics (SAGE)

During the past 52 weeks, Sage Therapeutics (SAGE) shares have fallen about 25%. Another reason for the decline in quotations is the drug's inability...

Related Stories

Leave A Reply

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.